CDRH Updates:: Invitrogen Corporation SPOT-Light(R) HER2 CISH(TM) Kit - P050040 Approval

This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval.

MORE ON THIS TOPIC